111 related articles for article (PubMed ID: 11888885)
21. Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors.
Talukder AH; Bagheri-Yarmand R; Williams RR; Ragoussis J; Kumar R; Raz A
Clin Cancer Res; 2002 Oct; 8(10):3285-9. PubMed ID: 12374700
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
23. RasGAP-associated endoribonuclease G3Bp: selective RNA degradation and phosphorylation-dependent localization.
Tourrière H; Gallouzi IE; Chebli K; Capony JP; Mouaikel J; van der Geer P; Tazi J
Mol Cell Biol; 2001 Nov; 21(22):7747-60. PubMed ID: 11604510
[TBL] [Abstract][Full Text] [Related]
24. A deletion mutant of heregulin increases the sensitivity of breast cancer cells to chemotherapy without promoting tumorigenicity.
Atlas E; Bojanowski K; Mehmi I; Lupu R
Oncogene; 2003 May; 22(22):3441-51. PubMed ID: 12776196
[TBL] [Abstract][Full Text] [Related]
25. Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells.
Li W; Park JW; Nuijens A; Sliwkowski MX; Keller GA
Oncogene; 1996 Jun; 12(11):2473-7. PubMed ID: 8649790
[TBL] [Abstract][Full Text] [Related]
26. Identification of metastasis associated gene G3BP by differential display in human cancer cell sublines with different metastatic potentials G3BP as highly expressed in non-metastatic.
Liu Y; Zheng J; Fang W; You J; Wang J; Cui X; Wu B
Chin Med J (Engl); 2001 Jan; 114(1):35-8. PubMed ID: 11779432
[TBL] [Abstract][Full Text] [Related]
27. Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta -catenin nuclear signaling in breast cancer cells by modulating the intercellular stability.
Adam L; Vadlamudi RK; McCrea P; Kumar R
J Biol Chem; 2001 Jul; 276(30):28443-50. PubMed ID: 11328805
[TBL] [Abstract][Full Text] [Related]
28. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
[TBL] [Abstract][Full Text] [Related]
29. Heregulins implicated in cellular functions other than receptor activation.
Breuleux M; Schoumacher F; Rehn D; Küng W; Mueller H; Eppenberger U
Mol Cancer Res; 2006 Jan; 4(1):27-37. PubMed ID: 16446404
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
31. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway.
Tsai PW; Shiah SG; Lin MT; Wu CW; Kuo ML
J Biol Chem; 2003 Feb; 278(8):5750-9. PubMed ID: 12471041
[TBL] [Abstract][Full Text] [Related]
33. Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.
Li Y; Yu WH; Ren J; Chen W; Huang L; Kharbanda S; Loda M; Kufe D
Mol Cancer Res; 2003 Aug; 1(10):765-75. PubMed ID: 12939402
[TBL] [Abstract][Full Text] [Related]
34. The N-terminal domain of G3BP enhances cell motility and invasion by posttranscriptional regulation of BART.
Taniuchi K; Nishimori I; Hollingsworth MA
Mol Cancer Res; 2011 Jul; 9(7):856-66. PubMed ID: 21665939
[TBL] [Abstract][Full Text] [Related]
35. [Monoclonal antibody against G3BP: preparation, characterization and its application in analysis of human tumors].
Ning JY; You JF; Pei F; Wang JL; Cui XL; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2005 Apr; 34(4):215-9. PubMed ID: 16091175
[TBL] [Abstract][Full Text] [Related]
36. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.
Vellon L; Menendez JA; Lupu R
Oncogene; 2005 May; 24(23):3759-73. PubMed ID: 15782133
[TBL] [Abstract][Full Text] [Related]
37. The HER2- and heregulin β1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression.
Asrani K; Keri RA; Galisteo R; Brown SA; Morgan SJ; Ghosh A; Tran NL; Winkles JA
Mol Cancer Res; 2013 Apr; 11(4):393-404. PubMed ID: 23378579
[TBL] [Abstract][Full Text] [Related]
38. Heregulin-induced cell migration is promoted by aryl hydrocarbon receptor in HER2-overexpressing breast cancer cells.
Yamashita N; Saito N; Zhao S; Terai K; Hiruta N; Park Y; Bujo H; Nemoto K; Kanno Y
Exp Cell Res; 2018 May; 366(1):34-40. PubMed ID: 29501698
[TBL] [Abstract][Full Text] [Related]
39. [G3BP: a promising target for cancer therapy].
Zhang H; Shao RG
Yao Xue Xue Bao; 2010 Aug; 45(8):945-51. PubMed ID: 21351580
[TBL] [Abstract][Full Text] [Related]
40. Evidence of Rab3A expression, regulation of vesicle trafficking, and cellular secretion in response to heregulin in mammary epithelial cells.
Vadlamudi RK; Wang RA; Talukder AH; Adam L; Johnson R; Kumar R
Mol Cell Biol; 2000 Dec; 20(23):9092-101. PubMed ID: 11074007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
